Workflow
Treace(TMCI)
icon
搜索文档
NVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Treace Medical Concepts, Inc of Class Action Lawsuit and Upcoming Deadlines - TMCI
Prnewswire· 2025-05-13 02:30
NEW YORK, May 12, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Treace Medical Concepts, Inc ("Treace Medical" or the "Company") (NASDAQ: TMCI).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns whether Treace Medical and ...
The Gross Law Firm Notifies Treace Medical Concepts, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – TMCI
GlobeNewswire News Room· 2025-05-13 01:05
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI). Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/treace-medical-concepts-inc-loss-submission-form-2/?id=147738&from=3 ...
Scott+Scott Attorneys at Law LLP Reminds Investors of Its Securities Class Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)
GlobeNewswire News Room· 2025-05-12 23:55
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Middle District of Florida against Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI), and certain of its former and current officers and/or directors (collectively, “Defendants”). The Class Action asserts claims under §§10(b) and 20(a ...
Shareholders that lost money on Treace Medical Concepts, Inc.(TMCI) should contact The Gross Law Firm about pending Class Action - TMCI
Prnewswire· 2025-05-12 17:45
NEW YORK, May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI).Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/treace-medical-concepts-inc-loss-submission-form-2/?id=147723&from=4CLASS PE ...
Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)
GlobeNewswire News Room· 2025-05-09 23:55
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Middle District of Florida against Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI), and certain of its former and current officers and/or directors (collectively, “Defendants”). The Class Action asserts claims under §§10(b) and 20(a ...
Treace Medical Concepts, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before June 10, 2025 to Discuss Your Rights - TMCI
Prnewswire· 2025-05-09 17:45
NEW YORK, May 9, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc." or the "Company") (NASDAQ: TMCI) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Treace Medical Concepts, Inc. investors who were adversely affected by alleged securities fraud between May 8, 2023 and May 7, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zl ...
Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates
ZACKS· 2025-05-09 07:20
Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 19.35%. A quarter ago, it was expected that this orthopedic medical device maker would post a loss of $0.03 per share when it actually produced a loss of $0.01, delivering a surprise of 66.67%.Over the last four qu ...
Treace(TMCI) - 2025 Q1 - Earnings Call Transcript
2025-05-09 05:32
Treace Medical Concepts (TMCI) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Company Participants Philip Taylor - PrincipalJohn Treace - CEO, Founder & ChairmanMark Hair - Chief Financial OfficerIseult McMahon - Equity Research AssociateFelipe Lamar - Senior Equity Research AssociateJayna Francis - Equity Research Associate Conference Call Participants Lilia-Celine Lozada - Analyst Operator Good day, and thank you for standing by. Welcome to the Therese Medical Concepts first quarter twenty twenty five ear ...
Treace(TMCI) - 2025 Q1 - Earnings Call Transcript
2025-05-09 05:30
Treace Medical Concepts (TMCI) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Speaker0 Good day, and thank you for standing by. Welcome to the Therese Medical Concepts first quarter twenty twenty five earnings conference call. At this time, all participants are in a listen only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising that your hand h ...
Treace(TMCI) - 2025 Q1 - Quarterly Report
2025-05-09 04:10
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from___ to___ Commission file number: 001-40355 Treace Medical Concepts, Inc. (Exact name of registrant as specified in its charter) Delaware 47-1052611 (State or ...